Danam Health, Inc. (WGRX)
Danam Health will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Danam Health Statistics
Total Valuation
Market Cap | n/a |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | 0.21 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.84 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -44.11% |
Revenue Per Employee | $1.70M |
Profits Per Employee | -$545,029 |
Employee Count | 31 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Danam Health had revenue of $52.75 million and -$16.90 million in losses.
Revenue | 52.75M |
Gross Profit | 4.99M |
Operating Income | -14.95M |
Pretax Income | -16.90M |
Net Income | -16.90M |
EBITDA | -14.41M |
EBIT | -14.43M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $2.17 million in cash and $34.87 million in debt, giving a net cash position of -$32.70 million.
Cash & Cash Equivalents | 2.17M |
Total Debt | 34.87M |
Net Cash | -32.70M |
Net Cash Per Share | n/a |
Equity (Book Value) | -967,126 |
Book Value Per Share | n/a |
Working Capital | -6.92M |
Cash Flow
Operating Cash Flow | -240,105 |
Capital Expenditures | n/a |
Free Cash Flow | -240,105 |
FCF Per Share | n/a |
Margins
Gross margin is 9.46%, with operating and profit margins of -28.35% and -32.03%.
Gross Margin | 9.46% |
Operating Margin | -28.35% |
Pretax Margin | -32.03% |
Profit Margin | -32.03% |
EBITDA Margin | -27.32% |
EBIT Margin | -27.35% |
FCF Margin | -0.46% |
Dividends & Yields
Danam Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |